← Back to Patent Explorer
US4623347A Expired / Lapsed US ⏱️ 0.0 years remaining

Antithrombogenic elastomer products

Assignee: Kanegafuchi Chemical Industry Co Ltd
•
Filing: 1985-04-08
•
Granted: 1986-11-18
•
Expires: 2005-04-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antithrombogenic elastomers comprising polyurethane or polyurethane urea, containing an organic silicone polymer in the main chain. A process for manufacturing such elastomers and molded products of such elastomers, are also disclosed.

Inventors

  • 👤 Kazuaki Kira

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:58
CPC Classifications
C; C08; C08G; C08G18/00; C08G18/06; C08G18/70; C08G18/72; C08G18/77; C08G18/778; A; A61; A61L; A61L27/00; A61L27/14; A61L27/18; A61L33/00; A61L33/06; A61L33/068; C08G18/28; C08G18/40; C08G18/48; C08G18/50; C08G18/5096; C08G18/61; Y; Y10; Y10S; Y10S623/00; Y10S623/902; Y10S623/903

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 78 words
A method for the prevention of the clotting of blood in contact with medical devices comprising forming at least the blood contact surfaces of said devices from an elastomer comprising thermoplastic polyurethane or polyurethane urea containing 4 to 15 weight % of polysiloxane having a molecular weight of 500 to 10,000 in the main chain, and containing a polyether or a polyester having a molecular weight of 500 to 6,000 as a soft segment other than said polysiloxane.
Claim 2
Independent Claim 78 words
A method for the prevention of the clotting of blood in contact with medical devices comprising forming at least the blood contact surfaces of said devices from an elastomer comprising thermoplastic polyurethane or polyurethane urea containing 4 to 15 weight % of polysiloxane having a molecular weight of 500 to 10,000 in the main chain, and containing a polyether or a polyester having a molecular weight of 500 to 6,000 as a soft segment other than said polysiloxane.
Claim 3
Dependent Claim 16 words
The method of claim 1, wherein said polysiloxane has a molecular weight of 700 to 3,000.
Claim 4
Dependent Claim 20 words
The method of claim 1, wherein said elastomer has a soft segment content of from 40 to 80 weight %.
Claim 5
Dependent Claim 11 words
The method of claim 1, wherein said polysiloxane is a polydimethylsiloxane.
Claim 6
Dependent Claim 60 words
The method of claim 4, wherein said polydimethylsiloxane is of the formula: ##STR7## wherein R 1 to R 6 each stand for an alkylene group having at least one carbon atom, a and e are both integers of from 0 to 30, b and d are both 0 or 1, and c is an integer of from 6 to 134.
Claim 7
Dependent Claim 14 words
The method of claim 1, wherein said medical device is an artificial blood vessel.
Claim 8
Dependent Claim 14 words
The method of claim 1, wherein said medical device is a blood bypass tube.
Claim 9
Dependent Claim 78 words
In the manufacture of blood-contacting medical devices from materials of a non-mammalian origin, the improvement comprising forming at least the blood-contacting surface of said medical device from an elastomer comprising thermoplastic polyurethane or polyurethane urea containing 4 to 15 weight % of polysiloxane having a molecular weight of 500 to 10,000 in the main chain, and containing a polyether or a polyester having a molecular weight of 500 to 6,000 as a soft segment other than said polysiloxane.
Claim 10
Dependent Claim 78 words
In the manufacture of blood-contacting medical devices from materials of a non-mammalian origin, the improvement comprising forming at least the blood-contacting surface of said medical device from an elastomer comprising thermoplastic polyurethane or polyurethane urea containing 4 to 15 weight % of polysiloxane having a molecular weight of 500 to 10,000 in the main chain, and containing a polyether or a polyester having a molecular weight of 500 to 6,000 as a soft segment other than said polysiloxane.

References Cited (Backward Citations)

US3246048A Cited
US3567499A Cited
GB2073219A Cited
US4528343A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-11-17 1990-05-19 1990-11-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-11-17 1994-05-19 1994-11-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-11-17 1998-05-19 1998-11-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag